SP15-3 Published on Saf Health Work 2022;13:S1eS86

Implementation of a harmonized approach for monitoring exposure to engineered and incidental nanoparticles and their potential health effects: First results from the EU-LIFE project NanoExplore. Published on Saf Health Work 2022;13:S1eS86.

Read publication here

Urinary Malondialdehyde (MDA) Concentrations in the General Population—A Systematic Literature Review and Meta-Analysis

Oxidative stress has been associated with various inflammation-related human diseases. It is defined as an imbalance between the production and elimination of reactive oxygen species (ROS). ROS can oxidize proteins, lipids, and DNA, and some of these oxidized products are excreted in urine, such as malondialdehyde (MDA), which is considered a biomarker for oxidative damage of lipids. To interpret changes of this biomarker as a measure of oxidative species overproduction in humans, a background range for urinary MDA concentration in the general population is needed.

Read publication here

Latest news & events

NANOTEXNOLOGY 2022 Thessaloniki, Greece Thessaloniki, Greece
More information
EU life programme turns 30!

Congratulations from NanoExplore on 30 years of LIFE...

More information
NanoInnovation Conference 2022 Rome, Italy Rome, Italy
More information
NanoExplore Workshop: Lessons learned from workplace exposure campaigns

You are cordially invited to the second one of the workshops organised by NanoExplore project. The workshop will take place online on 29 June...

More information